Infliximab for the treatment of rheumatoid arthritis.

BACKGROUND: Infliximab is a human murine chimeric anti-tumour necrosis factor alpha monoclonal antibody recently approved for the treatment of refractory RA. OBJECTIVES: To assess the efficacy and safety of infliximab for the treatment of rheumatoid arthritis. SEARCH STRATEGY: Electronic databases...

Descrizione completa

Dettagli Bibliografici
Autori principali: Blumenauer, B, Judd, M, Wells, G, Burls, A, Cranney, A, Hochberg, M, Tugwell, P
Natura: Journal article
Lingua:English
Pubblicazione: 2002